Julio Frenk, MD, MPH, PhD, dean of the Harvard School of Public Health, has announced that DF/HCC member Karen Emmons, PhD, has been appointed to the new role of Associate... | [more]
Welcome to Dana-Farber/Harvard Cancer Center
Dana-Farber/Harvard Cancer Center (DF/HCC) is the largest comprehensive cancer center in the world, bringing together the cancer research efforts of our seven member institutions: Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital, Children’s Hospital Boston, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, and Massachusetts General Hospital.Funded by a grant from the National Cancer Institute, we have joined these seven renowned Harvard-affiliated medical centers into one collective force dedicated to the fight against cancer. Based in Boston, DF/HCC consists of more than 1,000 researchers with a singular goal — to find new and innovative ways to combat cancer.
Announcements
- Request for Applications: DF/HCC SPORE in Skin Cancer Career Development Award Posted: 06-29-09
- Request for Applications: Travel Grant Opportunity: 2009 EORTC-NCI-ASCO Annual Meeting on “Molecular Markers in Cancer” Posted: 06-29-09
- Request for Applications: 2009 Harold Amos Faculty Diversity Award Posted: 06-22-09
Latest Cancer News
Emmons appointed to Associate Dean for Research
Summer eNews
The Summer edition of eNews, DF/HCC's quarterly newsletter, has just been published. This issue includes two feature articles on gastrointestinal malignancies... | [more]
Understanding environmental and genetic factors in GI malignancies
Whether you are currently studying gastrointestinal cancers or not, Charles Fuchs, MD, MPH (DFCI) may well try to recruit you as a member of the Gastrointestinal (GI)... | [more]
Leveraging genetics and technology in EGFR-mutated lung cancer
Activating mutations in the epidermal growth factor receptor (EGFR) occur in a unique subset of patients with non-small cell lung cancers (NSCLC). In advanced disease, the... | [more]
